Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic stem cell transplantation.

Barabanshikova MV, Zubarovsky IN, Savrasov VM, Korolkov AJ, Baykov VV, Botina AV, Vlasova JJ, Moiseev IS, Darskaya EI, Morozova EV, Afanasyev BV.

Hematol Oncol Stem Cell Ther. 2019 Apr 6. pii: S1658-3876(19)30026-3. doi: 10.1016/j.hemonc.2019.03.001. [Epub ahead of print]

2.

Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers.

Timin AS, Peltek OO, Zyuzin MV, Muslimov AR, Karpov TE, Epifanovskaya OS, Shakirova AI, Zhukov MV, Tarakanchikova YV, Lepik KV, Sergeev VS, Sukhorukov GB, Afanasyev BV.

ACS Appl Mater Interfaces. 2019 Apr 10;11(14):13091-13104. doi: 10.1021/acsami.8b22685. Epub 2019 Mar 27.

PMID:
30883080
3.

Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients.

Lepik KV, Mikhailova NB, Moiseev IS, Kondakova EV, Tsvetkova LA, Zalyalov YR, Borzenkova ES, Babenko EV, Baykov VV, Markova IV, Afanasyev BV.

Leuk Lymphoma. 2019 Feb 4:1-4. doi: 10.1080/10428194.2019.1573368. [Epub ahead of print] No abstract available.

PMID:
30712423
4.

Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.

Giebel S, Labopin M, Potter M, Poiré X, Sengeloev H, Socié G, Huynh A, Afanasyev BV, Schanz U, Ringden O, Kalhs P, Beelen DW, Campos AM, Masszi T, Canaani J, Mohty M, Nagler A.

Eur J Cancer. 2018 Jun;96:73-81. doi: 10.1016/j.ejca.2018.03.018. Epub 2018 Apr 18.

PMID:
29679774
5.

Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study.

Yaniv I, Krauss AC, Beohou E, Dalissier A, Corbacioglu S, Zecca M, Afanasyev BV, Berger M, Diaz MA, Kalwak K, Sedlacek P, Varotto S, Peters C, Bader P.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1629-1642. doi: 10.1016/j.bbmt.2018.03.002. Epub 2018 Mar 13.

PMID:
29548831
6.

Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.

Moiseev IS, Pirogova OV, Alyanski AL, Babenko EV, Gindina TL, Darskaya EI, Slesarchuk OA, Bykova TA, Chukhlovin AB, Pevtcov DE, Bondarenko SN, Afanasyev BV.

Eur J Haematol. 2018 May;100(5):395-402. doi: 10.1111/ejh.13030. Epub 2018 Mar 1.

PMID:
29360184
7.

Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis.

Barabanshikova MV, Dubina IA, Lapin SV, Morozova EV, Vlasova JJ, Ivanova MO, Moiseev IS, Afanasyev BV.

Oncol Res Treat. 2017;40(10):574-578. doi: 10.1159/000477253. Epub 2017 Sep 21.

8.

Efficient gene editing via non-viral delivery of CRISPR-Cas9 system using polymeric and hybrid microcarriers.

Timin AS, Muslimov AR, Lepik KV, Epifanovskaya OS, Shakirova AI, Mock U, Riecken K, Okilova MV, Sergeev VS, Afanasyev BV, Fehse B, Sukhorukov GB.

Nanomedicine. 2018 Jan;14(1):97-108. doi: 10.1016/j.nano.2017.09.001. Epub 2017 Sep 14.

PMID:
28917642
9.

Profiles of pro-inflammatory cytokines in allogenic stem cell transplantation with post-transplant cyclophosphamide.

Pirogova OV, Moiseev IS, Surkova EA, Lapin SV, Bondarenko SN, Kulagin AD, Afanasyev BV.

Cytokine. 2017 Nov;99:148-153. doi: 10.1016/j.cyto.2017.08.016. Epub 2017 Sep 9.

PMID:
28898706
10.

First experience of hematopoietic stem cell transplantation treatment of Shwachman-Diamond syndrome using unaffected HLA-matched sibling donor produced through preimplantation HLA typing.

Isaev AA, Deev RV, Kuliev A, Plaxa IL, Stancheva NV, Borovkova AS, Potapov IV, Pomerantseva EA, Chogovadze AG, Boyarsky KY, Semenenko AE, Mikhailov AV, Shevchenko KG, Prikhodko AV, Rechitsky S, Paina OV, Barchatov IM, Zubarovskaya LS, Verlinsky O, Bozo IY, Afanasyev BV.

Bone Marrow Transplant. 2017 Sep;52(9):1249-1252. doi: 10.1038/bmt.2017.46. Epub 2017 Mar 27.

11.

Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis.

Moiseev IS, Burmina EA, Muslimov AR, Pirogova OV, Bondarenko SN, Darskaya EI, Tarakanova YA, Senina NG, Afanasyev BV.

Ann Hematol. 2017 Jun;96(6):935-942. doi: 10.1007/s00277-017-2975-0. Epub 2017 Mar 25.

PMID:
28343273
12.

Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection.

Timin AS, Muslimov AR, Petrova AV, Lepik KV, Okilova MV, Vasin AV, Afanasyev BV, Sukhorukov GB.

Sci Rep. 2017 Mar 7;7(1):102. doi: 10.1038/s41598-017-00200-0.

13.

Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.

Pavlů J, Labopin M, Zoellner AK, Sakellari I, Stelljes M, Finke J, Fanin R, Stuhler G, Afanasyev BV, Bloor AJ, Anagnostopoulos A, Mohty M, Giebel S, Nagler A.

Cancer. 2017 Jun 1;123(11):1965-1970. doi: 10.1002/cncr.30604. Epub 2017 Feb 17.

14.

Mesenchymal Stem Cell Magnetization: Magnetic Multilayer Microcapsule Uptake, Toxicity, Impact on Functional Properties, and Perspectives for Magnetic Delivery.

Lepik KV, Muslimov AR, Timin AS, Sergeev VS, Romanyuk DS, Moiseev IS, Popova EV, Radchenko IL, Vilesov AD, Galibin OV, Sukhorukov GB, Afanasyev BV.

Adv Healthc Mater. 2016 Dec;5(24):3182-3190. doi: 10.1002/adhm.201600843. Epub 2016 Nov 18.

PMID:
27860430
15.

Intracellular redox induced drug release in cancerous and mesenchymal stem cells.

Timin AS, Lepik KV, Muslimov AR, Gorin DA, Afanasyev BV, Sukhorukov GB.

Colloids Surf B Biointerfaces. 2016 Nov 1;147:450-458. doi: 10.1016/j.colsurfb.2016.08.034. Epub 2016 Aug 23.

PMID:
27573039
16.

Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

Moiseev IS, Pirogova OV, Alyanski AL, Babenko EV, Gindina TL, Darskaya EI, Slesarchuk OA, Bondarenko SN, Afanasyev BV.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1037-1042. doi: 10.1016/j.bbmt.2016.03.004. Epub 2016 Mar 10.

17.

Efficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature Review.

Morozova EV, Vlasova YY, Pryanishnikova MV, Lepik KV, Afanasyev BV.

Biomark Insights. 2015 Dec 8;10(Suppl 3):43-7. doi: 10.4137/BMI.S22438. eCollection 2015. Review.

18.

[Bacterial infections in the early period after allogeneic bone marrow transplantation].

Vavilov VN, Averyanova MY, Bondarenko SN, Stancheva NV, Zubarovskaya LS, Afanasyev BV.

Ter Arkh. 2015;87(7):88-93. doi: 10.17116/terarkh201587788-93. Russian.

PMID:
26390730
19.

Level of vascular endothelial growth factor predicts both relapse and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.

Moiseev IS, Lapin SV, Surkova EA, Lerner MY, Vavilov VN, Afanasyev BV.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1677-82. doi: 10.1016/j.bbmt.2013.08.015. Epub 2013 Sep 10.

20.

Measurement of circulating endothelial cells to support the diagnosis of veno-occlusive disease after hematopoietic stem cell transplantation.

Moiseev IS, Babenko EV, Sipol AA, Vavilov VN, Afanasyev BV.

Int J Lab Hematol. 2014 Aug;36(4):e27-9. doi: 10.1111/ijlh.12137. Epub 2013 Aug 28. No abstract available.

PMID:
23981391

Supplemental Content

Loading ...
Support Center